Ibuvalen Duo (Ibuprofen, Codeine Phosphate Hemihydrate)

• Ibuvalen Duo combines ibuprofen and codeine to address pain and fever through anti‑inflammatory and opioid pathways.
• Mild to moderate pain: provides effective analgesia by reducing inflammation and activating µ‑opioid receptors.
• Fever: lowers elevated body temperature by inhibiting prostaglandin synthesis in the hypothalamus.
• Dental pain: relieves postoperative dental discomfort through combined analgesic actions.

• Ibuprofen blocks cyclooxygenase (COX‑1 and COX‑2) enzymes, decreasing prostaglandin production and thus reducing inflammation, pain, and fever. Codeine phosphate hemihydrate is metabolised to morphine, which binds to µ‑opioid receptors in the central nervous system, producing analgesia and a mild antitussive effect.

Ibuvalen Duo may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects

• Nausea or vomiting
• Constipation or abdominal discomfort
• Dizziness or drowsiness
• Headache
• Dry mouth
• Mild skin rash

Serious or Rare Side Effects

• Respiratory depression, especially with high doses or concurrent depressants
• Severe allergic reactions such as anaphylaxis or angioedema
• Gastrointestinal ulceration or bleeding
• Hepatic dysfunction or elevated liver enzymes
• Seizures in susceptible individuals
• Dependence or withdrawal symptoms with prolonged use

Before prescribing Ibuvalen Duo, clinicians should consider several safety measures.

• Renal function assessment: adjust use in patients with impaired kidney function.
• Gastrointestinal risk: avoid in individuals with active peptic ulcer disease or severe GI bleeding.
• CNS depressants: use caution when combined with alcohol, benzodiazepines, or other sedatives.
• Dependence monitoring: watch for signs of opioid dependence during extended therapy.
• Duration limitation: limit use to the shortest effective period to reduce adverse effects.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Ibuvalen Duo can interact with several medicines, requiring careful management.

Major Interactions (Avoid)

• MAO inhibitors: concurrent use may precipitate severe hypertension or serotonin syndrome.
• Other opioids or potent CNS depressants: increase risk of respiratory depression and profound sedation.

Moderate Interactions (Monitor Closely)

• Additional NSAIDs or anticoagulants: may heighten gastrointestinal bleeding risk.
• Antihypertensive agents: ibuprofen can reduce the antihypertensive effect.
• Selective serotonin reuptake inhibitors (SSRIs): combined use may increase bleeding tendency.
• CYP2D6 inhibitors (e.g., fluoxetine): may alter codeine metabolism and affect analgesic efficacy.